Condition: Hepatitis B · HIV · Sponsor: University of Alabama at Birmingham
Observational cohort of adults with acute and chronic hepatitis B infection in Zambia, with and without HIV coinfection. Participants join the study at the time of diagnosis and before or at the time when they are starting antiviral treatments and then they are followed up over multiple years to assess changes to their liver and evolution of HBV (and HIV if applicable) infection. All treatments for HBV and HIV are standard per local Ministry of Health guidelines.
This description comes directly from the study's public registry record.
Michael J Vinikoor, MD · 205-934-5191 · mjv3@uab.edu
Ike Oyewole · 205-996-0441 · ikeoluwaoyewole@uabmc.edu
Always discuss trial participation with your own doctor first.
| Kanyama Level 1 Hospital | Lusaka, Zambia | Recruiting |
| Matero Level 1 Hospital | Lusaka, Zambia | Recruiting |
| University Teaching Hospital | Lusaka, Zambia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07589985